{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T22:02:26Z","timestamp":1779746546679,"version":"3.53.1"},"reference-count":206,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019839","name":"Shenzhen Technology University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmech.2026.118665","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:39:44Z","timestamp":1770943184000},"page":"118665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Medicinal-chemistry-driven strategies for the synthesis of antiosteoclastogenic small molecules targeting RANKL and its downstream signaling pathways"],"prefix":"10.1016","volume":"308","author":[{"given":"Abdul","family":"Basit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0723-6237","authenticated-orcid":false,"given":"Siyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118665_bib1","doi-asserted-by":"crossref","first-page":"15311","DOI":"10.1021\/acs.jmedchem.4c00909","article-title":"Discovery of novel antiosteoporosis leads with bone resorption inhibition and anabolic promotion through a chemotype-assembly approach","volume":"67","author":"Huang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/endrev\/bnab028","article-title":"Secondary osteoporosis","volume":"43","author":"Ebeling","year":"2022","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejmech.2026.118665_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.18231\/j.ijor.2022.009","article-title":"Arthritis with osteoporosis crippled the elderly during Covid-19 pandemic: a silent killer?","volume":"8","author":"Govil","year":"2022","journal-title":"Int J Orthopaedic Rheumatol"},{"key":"10.1016\/j.ejmech.2026.118665_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2213-8587(22)00012-2","article-title":"Osteoporosis in men","volume":"10","author":"Vilaca","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ejmech.2026.118665_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21926\/obm.geriatr.2402277","article-title":"Osteoporosis etiology, epidemiology, diagnosis, diet, and treatment: a narrative review","volume":"8","author":"Foroutan","year":"2024","journal-title":"OBM Geriatrics"},{"key":"10.1016\/j.ejmech.2026.118665_bib6","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3390\/biomedicines11041220","article-title":"Physiopathology of osteoporosis: nursing involvement and management","volume":"11","author":"Valenzuela-Mart\u00ednez","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2026.118665_bib7","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2147\/JIR.S351918","article-title":"The rising era of \u201cImmunoporosis\u201d: role of immune system in the pathophysiology of osteoporosis","author":"Srivastava","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ejmech.2026.118665_bib8","series-title":"Orthopedic Issues in Osteoporosis","article-title":"Etiology and pathogenesis of osteoporosis","author":"Pietschmann","year":"2002"},{"key":"10.1016\/j.ejmech.2026.118665_bib9","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.3389\/fimmu.2018.02263","article-title":"Bone remodeling and the role of TRAF3 in osteoclastic bone resorption","volume":"9","author":"Boyce","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.118665_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbrc.2016.05.019","article-title":"Osteoclast function and bone-resorbing activity: an overview","volume":"476","author":"Soysa","year":"2016","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.ejmech.2026.118665_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115772","article-title":"Molecular and cellular mechanisms of osteoporosis","volume":"24","author":"Zhivodernikov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118665_bib12","first-page":"92","article-title":"Osteoporosis: a review of treatment options","volume":"43","author":"Tu","year":"2018","journal-title":"Pharmacy and Therapeutics"},{"key":"10.1016\/j.ejmech.2026.118665_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.medcli.2017.10.019","article-title":"Update on osteoporosis treatment","volume":"150","author":"Nogu\u00e9s","year":"2018","journal-title":"Med. Cl\u00ednica"},{"key":"10.1016\/j.ejmech.2026.118665_bib14","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.3390\/ijms23169465","article-title":"Current status of the diagnosis and management of osteoporosis","volume":"23","author":"Aibar-Almaz\u00e1n","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118665_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"17","author":"Gregson","year":"2022","journal-title":"Arch. Osteoporosis"},{"key":"10.1016\/j.ejmech.2026.118665_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112313","article-title":"Synthesis and biological activities of drugs for the treatment of osteoporosis","volume":"197","author":"Zhou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib17","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1021\/jm502014h","article-title":"Novel pyrazole derivatives effectively inhibit osteoclastogenesis, a potential target for treating osteoporosis","volume":"58","author":"Kuo","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib18","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1021\/acs.jmedchem.9b00270","article-title":"Benzylideneacetone derivatives inhibit osteoclastogenesis and activate osteoblastogenesis independently based on specific structure\u2013activity relationship","volume":"62","author":"Pativada","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118665_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s12276-024-01157-7","article-title":"Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases","volume":"56","author":"Takegahara","year":"2024","journal-title":"Experimental & molecular medicine"},{"key":"10.1016\/j.ejmech.2026.118665_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejmech.2018.08.044","article-title":"Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis","volume":"158","author":"Savino","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2018.07.009","article-title":"T63 inhibits osteoclast differentiation through regulating MAPKs and Akt signaling pathways","volume":"834","author":"Zhao","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118665_bib23","first-page":"297","article-title":"RANKL\/RANK\/OPG molecular complex-control factors in bone remodeling","volume":"53","author":"Drugarin","year":"2003","journal-title":"TMJ"},{"key":"10.1016\/j.ejmech.2026.118665_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115646","article-title":"Therapeutics of osteoarthritis and pharmacological mechanisms: a focus on RANK\/RANKL signaling","volume":"167","author":"Liang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.118665_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122331","article-title":"Binding-induced fibrillogenesis peptide inhibits RANKL-mediated osteoclast activation against osteoporosis","volume":"302","author":"Liang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2026.118665_bib26","doi-asserted-by":"crossref","first-page":"15738","DOI":"10.1021\/acs.jmedchem.4c01377","article-title":"Discovery of novel neo-clerodane derivatives as potent dual-functional antiosteoporosis agents through targeting peroxisome proliferator-activated Receptor-\u03b3","volume":"67","author":"Peng","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib27","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1038\/s41467-022-33006-4","article-title":"Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118665_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd3705","article-title":"Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab","volume":"11","author":"Lacey","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118665_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL\u2013RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2026.118665_bib30","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current understanding of RANK signaling in osteoclast differentiation and maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cells"},{"key":"10.1016\/j.ejmech.2026.118665_bib31","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1021\/acs.jmedchem.4c00438","article-title":"Design, synthesis, and biological evaluation of \u03b2-Trifluoroethoxydimethyl selenides as potent antiosteoporosis agents","volume":"67","author":"Wu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216175","article-title":"Role and regulation of transcription factors in osteoclastogenesis","volume":"24","author":"Jiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118665_bib33","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.3390\/molecules25173908","article-title":"Isoliquiritigenin derivatives inhibit RANKL-Induced osteoclastogenesis by regulating p38 and NF-\u03baB activation in RAW 264.7 cells","volume":"25","author":"Jeong","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118665_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast differentiation by RANKL and OPG signaling pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"J. Bone Miner. Metabol."},{"key":"10.1016\/j.ejmech.2026.118665_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00774-020-01175-1","article-title":"Discovery of the RANKL\/RANK\/OPG system","volume":"39","author":"Yasuda","year":"2021","journal-title":"J. Bone Miner. Metabol."},{"key":"10.1016\/j.ejmech.2026.118665_bib36","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1242\/jcs.115.14.2919","article-title":"Localization and possible role of two different alpha v beta 3 integrin conformations in resting and resorbing osteoclasts","volume":"115","author":"Faccio","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejmech.2026.118665_bib37","first-page":"55","article-title":"Puerarin specifically disrupts osteoclast activation via blocking integrin-\u03b23 Pyk2\/Src\/Cbl signaling pathway","volume":"33","author":"Qiu","year":"2022","journal-title":"J. Orthop. Transl."},{"key":"10.1016\/j.ejmech.2026.118665_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13287-023-03547-6","article-title":"Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins","volume":"14","author":"Bl\u00fcmke","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ejmech.2026.118665_bib39","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/s41467-024-46602-3","article-title":"Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118665_bib40","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.1021\/acs.jpcb.7b06687","article-title":"Unraveling binding interactions between human RANKL and its decoy receptor Osteoprotegerin","volume":"121","author":"Munasinghe","year":"2017","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2026.118665_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11154-014-9308-6","article-title":"RANKL\/OPG; critical role in bone physiology","volume":"16","author":"Martin","year":"2015","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ejmech.2026.118665_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.657","article-title":"Regulation of bone homeostasis: signaling pathways and therapeutic targets","volume":"5","author":"Wu","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.ejmech.2026.118665_bib43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40266-018-0525-7","article-title":"Denosumab: a review in postmenopausal osteoporosis","volume":"35","author":"Deeks","year":"2018","journal-title":"Drugs & aging"},{"key":"10.1016\/j.ejmech.2026.118665_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.maturitas.2017.04.008","article-title":"Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement","volume":"101","author":"Anagnostis","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.ejmech.2026.118665_bib45","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00223-010-9364-1","article-title":"Adverse effects of bisphosphonates","volume":"86","author":"Abrahamsen","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.ejmech.2026.118665_bib46","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.3390\/cancers15225366","article-title":"Bisphosphonates and their connection to dental procedures: exploring bisphosphonate-related osteonecrosis of the jaws","volume":"15","author":"Lee","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2026.118665_bib47","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.amjmed.2008.12.005","article-title":"Osteonecrosis of the jaw and the role of bisphosphonates: a critical review","volume":"122","author":"Silverman","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejmech.2026.118665_bib48","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jbmr\/zjaf037","article-title":"Denosumab discontinuation in the clinic: implications of rebound bone turnover and emerging strategies to prevent bone loss and fractures","volume":"40","author":"Kumar","year":"2025","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejmech.2026.118665_bib49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3803\/EnM.2021.1369","article-title":"Discontinuing denosumab: can it be done safely? A review of the literature","volume":"37","author":"Tay","year":"2022","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2026.118665_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154509","article-title":"Equol exerts a protective effect on postmenopausal osteoporosis by upregulating OPG\/RANKL pathway","volume":"108","author":"Ni","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2026.118665_bib51","first-page":"163","article-title":"Normal bone physiology, remodelling and its hormonal regulation","volume":"40","author":"Mallorie","year":"2022","journal-title":"Surgery"},{"key":"10.1016\/j.ejmech.2026.118665_bib52","series-title":"Bone Markers","first-page":"1","article-title":"Introduction: bone metabolism and its regulation","author":"Russell","year":"2024"},{"key":"10.1016\/j.ejmech.2026.118665_bib53","series-title":"Investigating the Role of Insulin-like Growth Factor (IGF) Axis in Stem Cell Based Periodontal Bone Regeneration in Osteoporotic Conditions","author":"Alghamdi","year":"2025"},{"key":"10.1016\/j.ejmech.2026.118665_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/CIA.S6083","article-title":"Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene","volume":"5","author":"Gennari","year":"2010","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.ejmech.2026.118665_bib55","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11914-017-0353-4","article-title":"Parathyroid hormone and parathyroid hormone-related protein analogs in osteoporosis therapy","volume":"15","author":"Leder","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.ejmech.2026.118665_bib56","article-title":"Osteoporosis treatment: current drugs and future developments","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118665_bib57","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1080\/14786419.2024.2362427","article-title":"Chemical compounds from Osmunda japonica and their NO inhibitory activity","volume":"39","author":"Feng","year":"2025","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2026.118665_bib58","series-title":"Heterocycles in Medicinal Chemistry","first-page":"3839","author":"Jampilek","year":"2019"},{"key":"10.1016\/j.ejmech.2026.118665_bib59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.11005\/jbm.2017.24.1.37","article-title":"The efficacy of bisphosphonates for prevention of osteoporotic fracture: an update meta-analysis","volume":"24","author":"Byun","year":"2017","journal-title":"J Bone Metab"},{"key":"10.1016\/j.ejmech.2026.118665_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115654","article-title":"Recent advance of small-molecule drugs for clinical treatment of osteoporosis: a review","volume":"259","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib72","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fmed.2017.00234","article-title":"Key triggers of osteoclast-related diseases and available strategies for targeted therapies: a review","volume":"4","author":"Bi","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.ejmech.2026.118665_bib61","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2012.11.011","article-title":"The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosis","volume":"53","author":"Nelson","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.ejmech.2026.118665_bib62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fcell.2020.00433","article-title":"Cathepsin K: the action in and beyond bone","volume":"8","author":"Dai","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2026.118665_bib63","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00198-014-2944-6","article-title":"Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the long-term odanacatib fracture trial","volume":"26","author":"Bone","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ejmech.2026.118665_bib64","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11657-023-01261-7","article-title":"Efficacy and safety of odanacatib for osteoporosis treatment: a systematic review and meta-analysis","volume":"18","author":"Chen","year":"2023","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.ejmech.2026.118665_bib65","doi-asserted-by":"crossref","first-page":"86","DOI":"10.7326\/M19-0675","article-title":"Disease-modifying effects of a novel cathepsin K inhibitor in osteoarthritis: a randomized controlled trial","volume":"172","author":"Conaghan","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2026.118665_bib66","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12967-018-1425-7","article-title":"The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis","volume":"16","author":"Lindstr\u00f6m","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.118665_bib67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.berh.2009.08.007","article-title":"Targeted therapies in osteoarthritis: a systematic review of the trials on www.clinicaltrials.gov","volume":"24","author":"Berenbaum","year":"2010","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.ejmech.2026.118665_bib68","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2008.03.009","article-title":"Drug-induced morphea: report of a case induced by balicatib and review of the literature","volume":"59","author":"Peroni","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejmech.2026.118665_bib69","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.joca.2009.03.015","article-title":"Protective effects of a cathepsin K inhibitor, SB-553484, in the canine partial medial meniscectomy model of osteoarthritis","volume":"17","author":"Connor","year":"2009","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ejmech.2026.118665_bib70","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.joca.2010.07.014","article-title":"Cathepsin K inhibition reduces CTXII levels and joint pain in the Guinea pig model of spontaneous osteoarthritis","volume":"18","author":"McDougall","year":"2010","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ejmech.2026.118665_bib71","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.3390\/ijms26072896","article-title":"Cathepsin K inhibitors as potential drugs for the treatment of osteoarthritis","volume":"26","author":"Brizuela","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118665_bib73","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s11658-022-00371-3","article-title":"Osteoporosis pathogenesis and treatment: existing and emerging avenues","volume":"27","author":"Liang","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejmech.2026.118665_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-018-0036-5","article-title":"Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis","volume":"7","author":"Nakai","year":"2019","journal-title":"Bone Res."},{"key":"10.1016\/j.ejmech.2026.118665_bib75","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.cmet.2024.03.005","article-title":"A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis","volume":"36","author":"Dong","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2026.118665_bib76","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3390\/antiox13121527","article-title":"Nrf2-Independent anti-inflammatory effects of dimethyl fumarate: challenges and prospects in developing electrophilic Nrf2 activators for neurodegenerative diseases","volume":"13","author":"Izumi","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2026.118665_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1264842","article-title":"Novel potential pharmacological applications of dimethyl Fumarate\u2014an overview and update","volume":"14","author":"Bresciani","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118665_bib78","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1302\/2046-3758.114.BJR-2020-0308.R2","article-title":"N, N-Dimethylformamide inhibits high glucose-induced osteoporosis via attenuating MAPK and NF-\u03baB signalling","volume":"11","author":"Liu","year":"2022","journal-title":"Bone & joint research"},{"key":"10.1016\/j.ejmech.2026.118665_bib79","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1039\/C9NP00061E","article-title":"The role of natural products in revealing NRF2 function","volume":"37","author":"Zhang","year":"2020","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2026.118665_bib80","doi-asserted-by":"crossref","first-page":"9747","DOI":"10.3390\/ijms26199747","article-title":"Synthesis and biological profile of omaveloxolone: the cornerstone for friedreich ataxia treatment","volume":"26","author":"Cordaro","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118665_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116587","article-title":"Therapeutic targeting of wnt antagonists by small molecules for treatment of osteoporosis","volume":"230","author":"Abhishek Shah","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118665_bib82","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1111\/febs.13081","article-title":"Lithium stimulates human bone marrow derived mesenchymal stem cell proliferation through GSK\u20103\u03b2\u2010dependent \u03b2\u2010catenin\/Wnt pathway activation","volume":"281","author":"Zhu","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2026.118665_bib83","article-title":"Acceleration of bone regeneration by activating Wnt\/\u03b2-catenin signalling pathway via lithium released from lithium chloride\/calcium phosphate cement in osteoporosis","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118665_bib84","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bcp.2014.06.011","article-title":"Acceleration of bone regeneration by local application of lithium: wnt signal-mediated osteoblastogenesis and wnt signal-independent suppression of osteoclastogenesis","volume":"90","author":"Arioka","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118665_bib85","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bone.2009.02.013","article-title":"A small molecule inhibitor of the wnt antagonist secreted frizzled-related protein-1 stimulates bone formation","volume":"44","author":"Bodine","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.ejmech.2026.118665_bib86","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.joca.2019.05.006","article-title":"Modulation of the wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment","volume":"27","author":"Deshmukh","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ejmech.2026.118665_bib87","doi-asserted-by":"crossref","first-page":"17226","DOI":"10.1021\/acs.jmedchem.4c01105","article-title":"Synthesis and antiosteoporotic characterization of diselenyl maleimides: discovery of a potent agent for the treatment of osteoporosis by targeting RANKL","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib99","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1039\/C5MD00482A","article-title":"Novel heterocyclic ring-fused oleanolic acid derivatives as osteoclast inhibitors for osteoporosis","volume":"7","author":"Wu","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2026.118665_bib119","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2017.03.008","article-title":"Synthesis of heterocyclic ring-fused tricyclic diterpene analogs as novel inhibitors of RANKL-induced osteoclastogenesis and bone resorption","volume":"131","author":"Wei","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib127","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ardp.201500475","article-title":"Development of 1\u2010Amino\u20104\u2010(phenylamino) anthraquinone\u20102\u2010sulfonate sodium derivatives as a new class of inhibitors of RANKL\u2010Induced osteoclastogenesis","volume":"349","author":"Lee","year":"2016","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2026.118665_bib144","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.bmc.2010.03.034","article-title":"A novel kavalactone derivative protects against H2O2-induced PC12 cell death via Nrf2\/ARE activation","volume":"18","author":"Tanaka","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115767","article-title":"Synthesis and evaluation of 2-NMPA derivatives as potential agents for prevention of osteoporosis in vitro and in vivo","volume":"260","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib156","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejmech.2015.05.015","article-title":"Discovery of 5-(2\u2032,4\u2032-difluorophenyl)-salicylanilides as new inhibitors of receptor activator of NF-\u03baB ligand (RANKL)-induced osteoclastogenesis","volume":"98","author":"Lee","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib158","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejmech.2016.04.007","article-title":"Design, synthesis and SARs of novel salicylanilides as potent inhibitors of RANKL-induced osteoclastogenesis and bone resorption","volume":"117","author":"Chen","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105361","article-title":"Synthesis of N-methylpyridine-chlorofuranformamide analogs as novel OPG up-regulators and inhibitors of RANKL-induced osteoclastogenesis","volume":"116","author":"Liu","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib172","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00044-024-03242-y","article-title":"Synthesis and characterization of new tetrakisphosphonic acid derivatives as FPPS inhibitors and evaluation of their anti-osteoclastogenic potential for prevention of osteoporosis","volume":"33","author":"Hassan","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.118665_bib186","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1021\/acs.jmedchem.3c00601","article-title":"Synthesis and biological evaluation of heterocyclic ring-fused 20 (S)-protopanaxadiol derivatives as potent antiosteoporosis agents","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib153","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1021\/acs.jmedchem.8b02027","article-title":"Development of small-molecules targeting receptor activator of nuclear Factor-\u03baB ligand (RANKL)\u2014Receptor activator of nuclear Factor-\u03baB (RANK) protein\u2013protein interaction by structure-based virtual screening and hit optimization","volume":"62","author":"Jiang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib152","doi-asserted-by":"crossref","first-page":"10216","DOI":"10.1021\/acs.jmedchem.5c00394","article-title":"Identification of a RANKL\/TNF-\u03b1 dual-inhibitor as a potential disease-modifying agent for the treatment of knee osteoarthritis","volume":"68","author":"Shao","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116335","article-title":"Discovery of a novel homoisoflavonoid derivative 5g for anti-osteoclastic bone loss via targeting FGFR1","volume":"270","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib185","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/acs.jmedchem.4c00349","article-title":"Synthesis of Heterocyclic ring-fused bisnoralcohol derivatives as novel small-molecule antiosteoporosis agents","volume":"67","author":"Zhang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib96","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/ddr.22104","article-title":"Microwave\u2010assisted synthesis of novel steroidal heterocyclic analogs as potent inhibitors of RANKL\u2010induced osteoclastogenesis","volume":"84","author":"Elmasry","year":"2023","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2026.118665_bib139","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1248\/bpb.b20-00063","article-title":"Fluorinated kavalactone inhibited RANKL-induced osteoclast differentiation of RAW264 cells","volume":"43","author":"Kumagai","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2026.118665_bib150","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/jcb.24744","article-title":"OA10 is a novel p38alpha mitogen\u2010activated protein kinase inhibitor that suppresses osteoclast differentiation and bone resorption","volume":"115","author":"Jiang","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2026.118665_bib165","doi-asserted-by":"crossref","first-page":"12043","DOI":"10.1021\/acs.jmedchem.0c01316","article-title":"Discovery of small-molecule inhibitors of receptor activator of nuclear factor-\u03bab ligand with a superior therapeutic index","volume":"63","author":"Rinotas","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bioorg.2018.03.005","article-title":"Synthesis of some novel orcinol based coumarin triazole hybrids with capabilities to inhibit RANKL-induced osteoclastogenesis through NF-\u03baB signaling pathway","volume":"78","author":"Krishna","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib167","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/1873-3468.12146","article-title":"Identification of a novel compound that inhibits osteoclastogenesis by suppressing nucleoside transporters","volume":"590","author":"Katsuyama","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2026.118665_bib130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ejmech.2016.08.004","article-title":"Synthesis and biological evaluation of rhein amides as inhibitors of osteoclast differentiation and bone resorption","volume":"123","author":"Xu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib157","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1016\/j.bmc.2015.06.007","article-title":"Novel inhibitors of RANKL-induced osteoclastogenesis: design, synthesis, and biological evaluation of 6-(2, 4-difluorophenyl)-3-phenyl-2H-benzo [e][1, 3] oxazine-2, 4 (3H)-diones","volume":"23","author":"Lee","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib160","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41419-021-03939-7","article-title":"A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-\u03ba B pathways","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118665_bib201","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170159","article-title":"OCLI-023, a novel pyrimidine compound, suppresses osteoclastogenesis in vitro and alveolar bone resorption in vivo","volume":"12","author":"Ihn","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118665_bib188","doi-asserted-by":"crossref","DOI":"10.1038\/srep22389","article-title":"A novel pyrazole derivative protects from ovariectomy-induced osteoporosis through the inhibition of NADPH oxidase","volume":"6","author":"Joo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118665_bib138","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fphar.2019.00367","article-title":"Inhibitory effect of KP-A038 on osteoclastogenesis and inflammatory bone loss is associated with downregulation of blimp1","volume":"10","author":"Ihn","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118665_bib191","doi-asserted-by":"crossref","first-page":"13676","DOI":"10.1021\/acs.jmedchem.1c01019","article-title":"Synthesis and biological evaluation of C-17-amino-substituted pyrazole-fused betulinic acid derivatives as novel agents for osteoarthritis treatment","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib132","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbmr.3604","article-title":"A novel rhein derivative modulates bone formation and resorption and ameliorates estrogen\u2010dependent bone loss","volume":"34","author":"Jiang","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejmech.2026.118665_bib88","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1021\/acs.jmedchem.9b00359","article-title":"Overview of recent strategic advances in medicinal chemistry","volume":"62","author":"Wu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib89","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/molecules25030505","article-title":"Synthesis of biologically active molecules through multicomponent reactions","volume":"25","author":"Insuasty","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118665_bib90","series-title":"Modern Strategies for Synthesis of Functionalized bio-molecules","first-page":"2525","author":"Banerjee","year":"2020"},{"key":"10.1016\/j.ejmech.2026.118665_bib91","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1038\/s41467-019-11976-2","article-title":"A general strategy for diversifying complex natural products to polycyclic scaffolds with medium-sized rings","volume":"10","author":"Zhao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118665_bib92","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.3390\/ijms26073203","article-title":"Recent advances in steroid discovery: structural diversity and bioactivity of marine and terrestrial steroids","volume":"26","author":"Hajda\u015b","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118665_bib93","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1039\/C2NP20082A","article-title":"Anticancer steroids: linking natural and semi-synthetic compounds","volume":"30","author":"Salvador","year":"2013","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2026.118665_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106516","article-title":"5\u03b1-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen receptor transactivation","volume":"241","author":"Schiffer","year":"2024","journal-title":"J Ster Biochem Mol Biol"},{"key":"10.1016\/j.ejmech.2026.118665_bib95","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fphar.2020.00360","article-title":"Pregnenolone inhibits osteoclast differentiation and protects against lipopolysaccharide-induced inflammatory bone destruction and ovariectomy-induced bone loss","volume":"11","author":"Sun","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118665_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116619","article-title":"Recent advances in the chemistry and biology of oleanolic acid and its derivatives","volume":"276","author":"Verma","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib98","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/nu14030623","article-title":"Oleanolic acid: extraction, characterization and biological activity","volume":"14","author":"Castellano","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2026.118665_bib100","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/j.ejmech.2008.12.024","article-title":"Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity","volume":"44","author":"Li","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib101","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/gme.0b013e3181fd7f4b","article-title":"Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss","volume":"18","author":"Zhao","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.ejmech.2026.118665_bib102","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11914-011-0087-7","article-title":"Nitric oxide donors for the treatment of osteoporosis","volume":"10","author":"Jamal","year":"2012","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.ejmech.2026.118665_bib103","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00198-012-2262-9","article-title":"The effects of organic nitrates on osteoporosis: a systematic review","volume":"24","author":"Jamal","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ejmech.2026.118665_bib104","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/ars.2015.6591","article-title":"Thiol-based redox modulation of soluble guanylyl cyclase, the nitric oxide receptor","volume":"26","author":"Beuve","year":"2017","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2026.118665_bib105","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400063","article-title":"Organoselenium compounds in medicinal chemistry","volume":"19","author":"Gallo\u2010Rodriguez","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.118665_bib106","first-page":"577","article-title":"Selenium: a trace element for a healthy skeleton-a narrative review, endocrine, metabolic & immune disorders-drug targets (formerly current drug targets-immune","volume":"21","author":"Vescini","year":"2021","journal-title":"Endocrine & Metabolic Disorders)"},{"key":"10.1016\/j.ejmech.2026.118665_bib107","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s00774-021-01240-3","article-title":"Selenium-modified calcium phosphate cement can accelerate bone regeneration of osteoporotic bone defect","volume":"39","author":"Li","year":"2021","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.ejmech.2026.118665_bib108","doi-asserted-by":"crossref","first-page":"23147","DOI":"10.1039\/D4RA04266B","article-title":"Zn (OTf) 2-catalyzed intra-and intermolecular selenofunctionalization of alkenes under mild conditions","volume":"14","author":"Qi","year":"2024","journal-title":"RSC advances"},{"key":"10.1016\/j.ejmech.2026.118665_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/polym14112208","article-title":"One-pot multicomponent polymerization, Metal-, and non-metal-catalyzed synthesis of organoselenium compounds","volume":"14","author":"Shaaban","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.ejmech.2026.118665_bib110","doi-asserted-by":"crossref","first-page":"15449","DOI":"10.1039\/D4RA01994F","article-title":"KI mediated one-pot cascade reaction for synthesis of 1, 3, 4-selenadiazoles","volume":"14","author":"Datta","year":"2024","journal-title":"RSC advances"},{"key":"10.1016\/j.ejmech.2026.118665_bib111","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/antiox5040042","article-title":"Biological chemistry of hydrogen selenide","volume":"5","author":"Cupp-Sutton","year":"2016","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2026.118665_bib112","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pbb.2006.02.002","article-title":"Bis selenide alkene derivatives: a class of potential antioxidant and antinociceptive agents","volume":"83","author":"Savegnago","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2026.118665_bib113","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1021\/acs.jmedchem.5b01409","article-title":"Analysis of past and present synthetic methodologies on medicinal chemistry: where have all the new reactions gone? Miniperspective","volume":"59","author":"Brown","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib114","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1021\/acs.chemrev.6b00274","article-title":"Oxetanes: recent advances in synthesis, reactivity, and medicinal chemistry","volume":"116","author":"Bull","year":"2016","journal-title":"Chemical reviews"},{"key":"10.1016\/j.ejmech.2026.118665_bib115","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00706-020-02586-6","article-title":"Applications of knoevenagel condensation reaction in the total synthesis of natural products","volume":"151","author":"Heravi","year":"2020","journal-title":"Monatshefte f\u00fcr Chemie-Chemical Monthly"},{"key":"10.1016\/j.ejmech.2026.118665_bib116","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.3390\/molecules26216598","article-title":"Phytochemistry and pharmacological activities of the diterpenoids from the genus daphne","volume":"26","author":"Nie","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118665_bib117","first-page":"1","article-title":"Diterpenoid compounds derived from meliaceae plants and biological activities","author":"Najihah","year":"2025","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.ejmech.2026.118665_bib118","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/cjoc.202400697","article-title":"Recent advances of terpenoids with intriguing chemical skeletons and biological activities","volume":"43","author":"Zang","year":"2025","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib120","article-title":"Design and evaluation of dual c-Met\/\u03b2-Tubulin inhibitors for triple-negative breast cancer: an In silico approach","author":"Mihajlovi\u0107","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib121","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1021\/jm500572b","article-title":"Medicinal chemistry of catechol O-methyltransferase (COMT) inhibitors and their therapeutic utility","volume":"57","author":"Kiss","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib122","doi-asserted-by":"crossref","first-page":"9565","DOI":"10.1021\/acs.chemrev.6b00144","article-title":"Hexaarylbenzene: evolution of properties and applications of multitalented scaffold","volume":"116","author":"Vij","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.118665_bib123","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/med.21391","article-title":"Anthraquinones as pharmacological tools and drugs","volume":"36","author":"Malik","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2026.118665_bib124","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.3390\/molecules28248139","article-title":"A review on bioactive anthraquinone and derivatives as the regulators for ROS","volume":"28","author":"Zhao","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118665_bib125","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3892\/etm.2020.8774","article-title":"STIM1 controls calcineurin\/Akt\/mTOR\/NFATC2-mediated osteoclastogenesis induced by RANKL\/M-CSF","volume":"20","author":"Huang","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2026.118665_bib126","first-page":"1","article-title":"Mechanisms of osteoclast activation in inflammatory bone loss in rheumatoid arthritis","author":"Rauner","year":"2025","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ejmech.2026.118665_bib128","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/578107","article-title":"Rhein: a review of pharmacological activities","volume":"2015","author":"Zhou","year":"2015","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.ejmech.2026.118665_bib129","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1007\/s00044-012-0215-7","article-title":"Synthesis and hypoglycemic activity evaluation of rhein amide derivatives","volume":"22","author":"Zhu","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.118665_bib131","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/02652048.2018.1467510","article-title":"Synthesis, screening and nanocrystals preparation of rhein amide derivatives","volume":"35","author":"Chen","year":"2018","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejmech.2026.118665_bib133","first-page":"36","article-title":"Imidazole and its biological activities: a review","volume":"1","author":"Shalini","year":"2010","journal-title":"Der Chemica Sinica"},{"key":"10.1016\/j.ejmech.2026.118665_bib134","series-title":"Nanostructured Biomaterials: Basic Structures and Applications","first-page":"135","article-title":"Overview on biological activities of imidazole derivatives","author":"Gujjarappa","year":"2022"},{"key":"10.1016\/j.ejmech.2026.118665_bib135","first-page":"1","article-title":"Imidazole derivatives synthesis: exploring different methods","author":"Parameswari","year":"2025","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"key":"10.1016\/j.ejmech.2026.118665_bib136","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/0118756298313032240529094738","article-title":"Research progress in chemical synthesis and biosynthesis of bioactive imidazole alkaloids","volume":"22","author":"Liu","year":"2025","journal-title":"Mini-Reviews Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib137","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1134\/S1070363225600043","article-title":"Synthesis, characterization, and molecular docking studies of chalcone-based imidazole derivatives as potential antioxidant agents","volume":"95","author":"Kamel","year":"2025","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib140","series-title":"The Synthesis of Novel Olfactory Receptor Agonists and Explorations in the Selective Fluorination of the tert-butyl Group for Bioactives Discovery","author":"Dobson","year":"2024"},{"key":"10.1016\/j.ejmech.2026.118665_bib141","series-title":"Fluorine in Heterocyclic Chemistry Volume 1: 5-Membered Heterocycles and Macrocycles","first-page":"1","article-title":"Tactical applications of fluorine in drug design and development","author":"Meanwell","year":"2014"},{"key":"10.1016\/j.ejmech.2026.118665_bib142","doi-asserted-by":"crossref","first-page":"699","DOI":"10.18311\/jnr\/2023\/32132","article-title":"Alpinia zerumbet: a review of the chemistry, quantity, and pharmacological properties of selected kavalactones","volume":"23","author":"Chan","year":"2023","journal-title":"J. Nat. Remedies"},{"key":"10.1016\/j.ejmech.2026.118665_bib143","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.bmcl.2017.04.016","article-title":"Synthesis of novel 5, 6-dehydrokawain analogs as osteogenic inducers and their action mechanisms","volume":"27","author":"Kumagai","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.118665_bib145","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s11655-013-1460-4","article-title":"Divergent immunomodulatory effects of extracts and phenolic compounds from the fern Osmunda japonica thunb","volume":"19","author":"Zhu","year":"2013","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.ejmech.2026.118665_bib146","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.biocel.2012.04.003","article-title":"Licorice isoliquiritigenin suppresses RANKL-Induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo","volume":"44","author":"Zhu","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118665_bib147","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bcp.2016.03.002","article-title":"Anti-osteoclastogenic activity of isoliquiritigenin via inhibition of NF-\u03baB-dependent autophagic pathway","volume":"106","author":"Liu","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118665_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202403434","article-title":"Sulfonamides as a promising scaffold in drug discovery: an insightful review on FDA\u2010Approved molecules, synthesis strategy, medical indication, and their binding mode","author":"Aslam","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2026.118665_bib149","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1039\/D1OB01091C","article-title":"Unconventional approaches for the introduction of sulfur-based functional groups","volume":"19","author":"Lanfranco","year":"2021","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib151","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.3390\/molecules23123139","article-title":"Inhibitory effects of 2N1HIA (2-(3-(2-Fluoro-4-Methoxyphenyl)-6-Oxo-1 (6H)-Pyridazinyl)-N-1H-Indol-5-Ylacetamide) on osteoclast differentiation via suppressing cathepsin K expression","volume":"23","author":"Ahn","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118665_bib154","article-title":"Self\u2010assembled myricetin\u2010arginine conjugate nanozymes for targeted suppression of joint inflammation and osteoclastogenesis in rheumatoid arthritis","author":"Hong","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2026.118665_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313121","article-title":"Overcoming challenges in small-molecule drug bioavailability: a review of key factors and approaches","volume":"25","author":"Wu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118665_bib161","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/hmg\/ddr510","article-title":"A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF","volume":"21","author":"Douni","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2026.118665_bib162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005372","article-title":"Cheminformatics-aided discovery of small-molecule protein-protein interaction (PPI) dual inhibitors of tumor necrosis factor (TNF) and receptor activator of NF-\u03baB ligand (RANKL)","volume":"13","author":"Melagraki","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejmech.2026.118665_bib163","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1126\/science.1116304","article-title":"Small-molecule inhibition of TNF-\u03b1","volume":"310","author":"He","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118665_bib164","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411290","article-title":"Structure-based discovery of receptor activator of nuclear factor-\u03baB ligand (RANKL)-induced osteoclastogenesis inhibitors","volume":"24","author":"Rinotas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118665_bib166","series-title":"Medicinal Chemistry and Drug Development","first-page":"689","article-title":"Chapter 28 - bisphosphonates: a targeted therapeutic medication for skeletal system","author":"Han","year":"2025"},{"key":"10.1016\/j.ejmech.2026.118665_bib168","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fphar.2019.00103","article-title":"A novel small molecule which increases osteoprotegerin expression and protects against ovariectomy-related bone loss in rats","volume":"10","author":"Han","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118665_bib169","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/1087057116654657","article-title":"Development of a high-throughput screening strategy for upregulators of the OPG\/RANKL ratio with the potential for antiosteoporosis effects","volume":"21","author":"Gong","year":"2016","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2026.118665_bib171","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.ymthe.2024.03.001","article-title":"Engineering small-molecule and protein drugs for targeting bone tumors","volume":"32","author":"Wang","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2026.118665_bib173","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/10426507.2017.1284844","article-title":"Conversion of nitriles to 1-aminophosphonic acids and preparation of phosphahomocysteines of high enantiomeric excess","volume":"192","author":"Qian","year":"2017","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"key":"10.1016\/j.ejmech.2026.118665_bib174","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1021\/acs.chemrev.6b00536","article-title":"Phosphonate biochemistry","volume":"117","author":"Horsman","year":"2017","journal-title":"Chemical reviews"},{"key":"10.1016\/j.ejmech.2026.118665_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103282","article-title":"Rational design of some substituted phenyl azanediyl (bis) methylene phosphonic acid derivatives as potential anticancer agents and imaging probes: computational inputs, chemical synthesis, radiolabeling, biodistribution and gamma scintigraphy","volume":"92","author":"Khedr","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib176","series-title":"Clinical Applications of Nuclear Medicine Targeted Therapy","first-page":"345","article-title":"Radiopharmaceuticals for bone metastases","author":"Pagano","year":"2018"},{"key":"10.1016\/j.ejmech.2026.118665_bib177","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bmcl.2014.12.016","article-title":"A comparative study of trans-and cis-isomers of a bone-seeking agent","volume":"25","author":"Hao","year":"2015","journal-title":"DO2A2P, Bioorganic & medicinal chemistry letters"},{"key":"10.1016\/j.ejmech.2026.118665_bib178","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.3390\/molecules27196552","article-title":"Semisynthetic derivatives of pentacyclic triterpenes bearing heterocyclic moieties with therapeutic potential","volume":"27","author":"Nistor","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118665_bib179","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1055\/a-1543-9719","article-title":"Advances in the semi-synthesis of triterpenoids","volume":"53","author":"Liao","year":"2021","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2026.118665_bib180","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1039\/D2NP00063F","article-title":"Natural products of pentacyclic triterpenoids: from discovery to heterologous biosynthesis","volume":"40","author":"Li","year":"2023","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2026.118665_bib181","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/chemistry6050067","article-title":"Advances in research on Semi-Synthesis, biotransformation and biological activities of novel derivatives from maslinic acid","volume":"6","author":"Trabelsi","year":"2024","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2026.118665_bib182","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.steroids.2018.02.001","article-title":"New product identification in the sterol metabolism by an industrial strain Mycobacterium neoaurum NRRL B-3805","volume":"132","author":"Li","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2026.118665_bib183","article-title":"Unraveling and engineering the production of 23, 24-bisnorcholenic steroids in sterol metabolism","volume":"6","author":"Xu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118665_bib184","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1877946813666221021144829","article-title":"A review on the synthesis and pharmacological activity of heterocyclic compounds","volume":"13","author":"Baranwal","year":"2023","journal-title":"Curr. Phys. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib187","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbrc.2022.02.023","article-title":"Icariin inhibits RANKL-induced osteoclastogenesis in RAW264. 7 cells via inhibition of reactive oxygen species production by reducing the expression of NOX1 and NOX4","volume":"600","author":"Ji","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.118665_bib189","first-page":"4080","article-title":"Ajuga decumbens stimulates mesenchymal stem cell differentiation and regenerates cartilage in a rabbit osteoarthritis model","volume":"15","author":"Sawada","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2026.118665_bib190","first-page":"4561","article-title":"Evaluation of the efficacy of Ajuga decumbens extract supplement in individuals with knee discomfort associated with physical activity: a randomized, double-blind, placebo-controlled study","volume":"14","author":"Sawada","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2026.118665_bib193","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1039\/c3cs60386e","article-title":"Beyond click chemistry\u2013supramolecular interactions of 1, 2, 3-triazoles","volume":"43","author":"Schulze","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2026.118665_bib194","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jhet.70006","article-title":"Synthesis of novel 1, 2, 3\u2010Triazole derivatives via click chemistry and evaluation of their antifungal activity","volume":"62","author":"Zhang","year":"2025","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2026.118665_bib196","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbrc.2015.04.034","article-title":"Esculetin attenuates receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation through c-Fos\/nuclear factor of activated T-cells c1 signaling pathway","volume":"461","author":"Baek","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.118665_bib197","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11094-025-03390-4","article-title":"Prospects for using 1, 2, 3-Triazole derivatives in medicinal chemistry","volume":"59","author":"Kukov","year":"2025","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2026.118665_bib198","doi-asserted-by":"crossref","DOI":"10.1080\/17518253.2024.2307989","article-title":"Biological importance and synthesis of 1, 2, 3-triazole derivatives: a review","volume":"17","author":"Vaishnani","year":"2024","journal-title":"Green Chem. Lett. Rev."},{"key":"10.1016\/j.ejmech.2026.118665_bib199","first-page":"1","article-title":"Targeting NF-\u03baB in diabetic nephropathy: exploring the therapeutic potential of phytoconstituents","author":"Abhirami","year":"2025","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2026.118665_bib200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142201","article-title":"Inhibitory effects of kp-a159, a thiazolopyridine derivative, on osteoclast differentiation, function, and inflammatory bone loss via suppression of rankl-induced map kinase signaling pathway","volume":"10","author":"Ihn","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118665_bib202","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1177\/1535370215576310","article-title":"The 1, 2, 3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway","volume":"240","author":"Ihn","year":"2015","journal-title":"Experimental Biology and Medicine"},{"key":"10.1016\/j.ejmech.2026.118665_bib203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/138920006775541552","article-title":"Preclinical pharmacokinetics: an approach towards safer and efficacious drugs","volume":"7","author":"Singh","year":"2006","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2026.118665_bib204","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00003088-200342060-00002","article-title":"Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges","volume":"42","author":"Masimirembwa","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2026.118665_bib205","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41392-023-01467-8","article-title":"Targeting strategies for bone diseases: signaling pathways and clinical studies","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.118665_bib206","article-title":"In vitro and in vivo assessment of ADME and PK properties during lead selection and lead optimization\u2013guidelines","author":"Chung","year":"2015","journal-title":"benchmarks and rules of thumb"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T21:07:35Z","timestamp":1779743255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426001108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":206,"alternative-id":["S0223523426001108"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118665","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medicinal-chemistry-driven strategies for the synthesis of antiosteoclastogenic small molecules targeting RANKL and its downstream signaling pathways","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118665"}}